Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Case Study on Management of Metabolic Disease: Maple Syrup Urine Disease (MSUD), Slides of Pediatrics

This case study presents a patient with maple syrup urine disease (msud), a rare inherited metabolic disorder caused by a deficiency of the branched-chain α-ketoacid dehydrogenase complex. The patient's symptoms, diagnosis, and management, including dietary treatment and emergency management. The document also provides an overview of newborn screening and its relevance to healthcare professionals.

Typology: Slides

2011/2012

Uploaded on 12/21/2012

devaku
devaku 🇮🇳

4.2

(11)

136 documents

1 / 25

Toggle sidebar

Related documents


Partial preview of the text

Download Case Study on Management of Metabolic Disease: Maple Syrup Urine Disease (MSUD) and more Slides Pediatrics in PDF only on Docsity! Management of Metabolic Disease Docsity.com Case Study--JC 11.5 mo male with MSUD presents to metabolic clinic for continued mgt of his IEM. PMHx: FT, normal at birth. Poor feeding and increased lethargy 1st week of life. Frequent calls to MD--mother told this was normal behavior DOL 7 to 10--continued poor feeding and lethargy; was taken to the pediatrician and placed on Prosobee formula DOL 11--unarousable. Admitted to hospital for dehydration and begun on nasogastric tube feeds of Similac. Admit labs: WBC 12.0, UA 1+ ketones, CO2 19, anion gap 8, glucose 63. Sepsis workup begun Docsity.com Maple Syrup Urine Disease • Autosomal recessive inheritance • Infants are normal at birth • In severe forms, seizures, apnea, and death can occur within 10 days of birth • Branched-chain α-ketoacid dehydrogenase complex (BCKAD) deficiency • Elevated levels of branched-chain ketoacids, their amino acid precursors, and alloisoleucine Docsity.com Treatment • These children decompensate within the first few days of life – Delayed or missed dx leads to coma and death • Goal is to identify affected infants before they crash – Not all states screen for MSUD – Screen is often not back before the child becomes symptomatic Docsity.com Treatment cont: • Diagnose and initiate treatment as soon as possible – Emergency therapy – Life-time dietary treatment – Liver transplantation – Gene therapy and others are still some years in the future Docsity.com • PKU – 10 mo old – A set of 2 yr old identical twins, former 25 wk premmies – 2 high school students • Homocystinemia – 1 high school student • MCAD – 12 mo old dx on NBS Our population changes constantly and you never know what you might get! Docsity.com – Good possibility that one or more of these kids will be admitted to the ER or the Ward on YOUR watch Docsity.com Overview • Newborn Screening • Dietary treatment • Emergency management • Long term issues Docsity.com Brief History of NBS • Began in 1963 in MA with screening for PKU – Guthrie developed a bacterial inhibition assay for phenylalanine using a dried blood filter paper card. • By 1967, mandatory PKU testing in most states • 70’s and 80’s, additional tests from the “Guthrie” card were developed (galactosemia, MSUD, biotinidase, homocystinemia, congenital hypothyroidism, CAH) – Up to 8 diseases were included in NBS (varied by state) • 1990’s, tandum mass spectrometry technology was developed which allows for detection of a greater number of disorders of amino acid, organic acid, and fatty acid metabolism (see handout) Docsity.com Newborn Screening is State Public Health Activity • Federal govt recommends screening for PKU, congenital hypothyroidism, and sickle cell disease • Each state is responsible for designing and implementing its own program – Which disorders to include in the screen – Whether parental consent is required • 33 states allow exemptions for religious reasons 13 states allow exemptions for any reason – Whether they will use a state-run lab or contract out to a private lab Docsity.com • Just because TMS technology is used in a state, it does not mean that that state performs the “expanded” screen. Docsity.com Why Does Dietary Treatment Keep these Kids Alive and Protect Their Brains? Docsity.com Because…... • Biochemical defect is known – absent or minimal production of enzyme system that breaks down dietary constituents • With the amino acidopathies (MSUD, MMA, PKU), defect involves dietary constituents that are “essential” – Restrict the precursors to the toxic metabolites • We can use consequences of the defect to design our therapy Docsity.com What Happens in PKU? Phenylalanine tyrosine DOPA, NE, EPI, Melanin Absent phenylalanine hydroxylase Food Catabolized tissue Docsity.com
Docsity logo



Copyright © 2024 Ladybird Srl - Via Leonardo da Vinci 16, 10126, Torino, Italy - VAT 10816460017 - All rights reserved